BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31633831)

  • 1. Expanded FDA regulation of health and wellness apps.
    Kasperbauer TJ; Wright DE
    Bioethics; 2020 Mar; 34(3):235-241. PubMed ID: 31633831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
    Roller ST; Pippins RR; Ngai JW
    Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the Food and Drug Administration's Risk-Based Framework for Software Precertification With Top Health Apps in the United States: Quality Improvement Study.
    Alon N; Stern AD; Torous J
    JMIR Mhealth Uhealth; 2020 Oct; 8(10):e20482. PubMed ID: 32927429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Federal Trade Commission and Consumer Protections for Mobile Health Apps.
    Wagner JK
    J Law Med Ethics; 2020 Mar; 48(1_suppl):103-114. PubMed ID: 32342745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. This Article Makes You Smarter! (Or, Regulating Health and Wellness Claims).
    Duranske S
    Am J Law Med; 2017 Mar; 43(1):7-55. PubMed ID: 29086609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time for Change: Stepping Up the FDA's Regulation of Dietary Supplements to Promote Consumer Safety and Awareness.
    Kennett G
    J Law Health; 2019; 33(1):47-78. PubMed ID: 31841617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marketing health care products on the Internet: a proposal for updated federal regulations.
    Green K
    Am J Law Med; 1998; 24(2-3):365-86. PubMed ID: 9702278
    [No Abstract]   [Full Text] [Related]  

  • 8. Can You Diagnose Me Now? A Proposal to Modify FDA's Regulation of Smartphone Mobile Health Applications with a Pre-Market Notification and Application Database System.
    McInerney S
    Food Drug Law J; 2015; 70(1):161-85, ii. PubMed ID: 26292476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA Regulation of Mobile Medical Apps.
    Shuren J; Patel B; Gottlieb S
    JAMA; 2018 Jul; 320(4):337-338. PubMed ID: 29971339
    [No Abstract]   [Full Text] [Related]  

  • 10. APPlying knowledge: evidence for and regulation of mobile apps for dermatologists.
    Chan CX; Markowitz O
    Cutis; 2020 Aug; 106(2):76-78. PubMed ID: 32941561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "Hot Potato" of Mental Health App Regulation: A Critical Case Study of the Australian Policy Arena.
    Parker L; Bero L; Gillies D; Raven M; Grundy Q
    Int J Health Policy Manag; 2019 Mar; 8(3):168-176. PubMed ID: 30980633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Don’t Try This at Home: the FDA’s Restrictive Regulation of Home Testing Devices.
    Baird S
    Duke Law J; 2017 Nov; 67(2):383-426. PubMed ID: 29469551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health Apps and Health Policy: What Is Needed?
    Bates DW; Landman A; Levine DM
    JAMA; 2018 Nov; 320(19):1975-1976. PubMed ID: 30326025
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA statutory authority to regulate the safety of dietary supplements.
    Hutt PB
    Am J Law Med; 2005; 31(2-3):155-74. PubMed ID: 16146287
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division.
    Villafranco JE; Lustigman AB
    Food Drug Law J; 2007; 62(4):709-25. PubMed ID: 18557227
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA regulation of mobile health technologies.
    Cortez NG; Cohen IG; Kesselheim AS
    N Engl J Med; 2014 Jul; 371(4):372-9. PubMed ID: 25054722
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA's misplaced priorities: premarket review under the Family Smoking Prevention and Tobacco Control Act.
    Jenson D; Lester J; Berman ML
    Tob Control; 2016 May; 25(3):246-53. PubMed ID: 27068243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA'S food ingredient approval process: Safety assurance based on scientific assessment.
    Rulis AM; Levitt JA
    Regul Toxicol Pharmacol; 2009 Feb; 53(1):20-31. PubMed ID: 18983884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A health app developer's guide to law and policy: a multi-sector policy analysis.
    Parker L; Karliychuk T; Gillies D; Mintzes B; Raven M; Grundy Q
    BMC Med Inform Decis Mak; 2017 Oct; 17(1):141. PubMed ID: 28969704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticipating new consumer protection challenges in the food and drug marketplace.
    Parnes LB
    Food Drug Law J; 2008; 63(2):593-9. PubMed ID: 18561480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.